IL-6 and TNFα Genetic Mutations and Immunological Response in Salmonellosis
Zina Murshd Kadim 1, Nahla Ghazi Mohammed Al Loza 2,4*, Teba Habeeb Sayfe 3
Journal of Angiotherapy 8(5) 1-7 https://doi.org/10.25163/angiotherapy.859668
Submitted: 17 March 2024 Revised: 06 May 2024 Published: 11 May 2024
Abstract
Background: Understanding the genetic and immunological aspects of Salmonella infection is essential for effective management and prevention strategies. This study aimed to investigate the prevalence of Salmonella IgM and IgG antibodies, as well as the concentrations of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα), in patients with suspected Salmonella infection compared to healthy controls. Additionally, genetic mutations in the IL-6 and IFNα genes were explored. Methods: Between March and November 2023, blood samples were collected from 60 patients visiting Baghdad Teaching Hospital and 30 healthy individuals serving as the control group. ELISA assays were performed to measure Salmonella IgM and IgG levels, while IL-6 and TNFα concentrations were determined. Genetic mutations in the IL-6 (rs1800799) and IFNα (rs2430560) genes were analyzed using molecular techniques. Results: The mean levels of Salmonella IgM and IgG did not significantly differ between males and females (p = 0.21 and p = 0.58, respectively). Similarly, there were no significant gender differences in IL-6 and TNFα concentrations (p = 0.55 and p = 0.55, respectively). Mutations were observed in the IL-6 gene (rs1800799), resulting in variations from the wild AA variant to AG, AG, GG, GG, GG, AG, AG, GG, AG, and GG. Additionally, mutations were detected in the IFNα gene (rs2430560), with the wild TT variant changing to TA, TA, TA, AA, AA, TA, TA, AA, TT, and AA. Conclusion: This study provides insights into the immunological and genetic aspects of Salmonella infection. The lack of significant gender differences in antibody levels and cytokine concentrations suggests a similar immune response between males and females. The identification of genetic mutations in the IL-6 and IFNα genes highlights the genetic variability associated with Salmonella infection and warrants further investigation into their clinical implications.
Keywords: Salmonellosis, genetic mutations, immunological response, IL-6, TNFα
References
Abbott SL, Janda JM, Johnson JA Farmer JJ III: Vibrio. In Versalovic J, Carroll KC, Funke G, et al. Manual of Clinical Microbiology, 10th ed. ASM Press, 2011.
Allos BM, Blaser MJ: Campylobacter jejuni and related species. In Mandell GL, Bennett JE, Dolin R. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 7th ed. Elsevier, 2010.
Ameer H.R. Chiwan and Ibrahim M.S. Shnawa, Diagnostic Validity of Urinary Mucosal Anti – Salmonella typhi OMP Antibodies as Compared to Systemic Responses in Typhoid Patients, J. of population Thearaput. and clinic. Pharma. Vol. 30 No. 12 (2023): JPTCP. DOI https:// doi.org/10.47750/jptcp.2023.30.12.012.
Blaser MJ: Helicobacter pylori and other gastric Helicobacter species. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 7th ed. Elsevier, 2010.
Calenge, F. Kaiser, P. and Vignal, A. Genetic control of resistance to salmonellosis and to Salmonella carrier-state in fowl: a review, Genetics Selection Evolution volume 42, Article number: 11 (2010).
Chiwan, A.H., Shnawa, I.M. and Abd, F.G., Genome DNA Sequencing, Phylogenetic Dendrogram and Outer Membrane Protein Separation Studies of Local Najaf S. typhi Isolates/Iraq. HIV Nursing, 23(1), pp.1125-1128(2023).
Dahora, L. C. Jin, C. and Spreng, R. S. et al., IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model, Front Immunol. 2019; 10: 2582.
Fitzgerald C, Nachamkin I: Campylobacter and Arcobacter. In Versalovic J, Carroll KC, Funke G, et al. Manual of Clinical Microbiology, 10th ed. ASM Press, 2011.
Fu-Ch. Upregulation of Salmonella-Induced IL-6 Production in Caco-2 Cells by PJ-34, PARP-1 Inhibitor: Involvement of PI3K, p38 MAPK, ERK, JNK, and NF-κB Mediators Inflamm. 2009; 2009: 103890.
Guo, Y. Gu, D. and Huang, T. et al., Essential role of Salmonella Enteritidis DNA adenine methylase in modulating inflammasome activation, BMC Microbiology volume 20, Article number: 226 (2020),
Horneman AJ, Ali A: Aeromonas. In Versalovic J, Carroll KC, Funke G, et al (editors). Manual of Clinical Microbiology,
Jin, C.; Gibani, M.M.; Moore, M.; Juel, H.B.; Jones, E.; Meiring, J.; Harris, V.; Gardner, J.; Nebykova, A.; Kerridge, S.A.; et al. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: A randomised controlled, phase 2b trial. Lancet 2017, 390, 2472–2480.
Jones, E. Celina Jin, C. and Stockdale, L. et al., A Salmonella Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination, Microorganisms. 2021 Jul; 9(7): 1394.
Mohan, V.K.; Varanasi, V.; Singh, A.; Pasetti, M.F.; Levine, M.M.; Venkatesan, R.; Ella, K.M. Safety and Immunogenicity of a Vi Polysaccharide-Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study. Clin. Infect. Dis. 2015, 61, 393–402.
Najib, M. A., Mustaffa, K. M. F., Ong, E. B. B., Selvam, K., Khalid, M. F., Awang, M. S., Zambry, N. S., Manaf, A. A., Bustami, Y., Hamzah, H. H., Ismail, A. & Aziah, I. (2021). Performance of Immunodiagnostic Tests for Typhoid Fever: A Systematic Review and Meta-Analysis. Pathogens, 10, 11
Pham, T. H. M. Brewer, S. M. and Thurston, T. et al., Salmonella-Driven Polarization of Granuloma Macrophages Antagonizes TNF-Mediated Pathogen Restriction during Persistent Infection, Cell Host and Microbe J. Volume 27, Issue 1, 8 January 2020, Pages 54-67.e5.
Qadri, F. Khanam, F. and Liu, X. et al., Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial, Lancet. 2021 Aug 21; 398(10301): 675–684. doi: 10.1016/S0140-6736(21)01124-7.
Seas C, DuPont HL, Valdez LM, Gotuzzo E: Practical guidelines for the treatment of cholera. Drugs 1996;51:966–973.
Shakya, M.; Colin-Jones, R.; Theiss-Nyland, K.; Voysey, M.; Pant, D.; Smith, N.; Liu, X.; Tonks, S.; Mazur, O.; Yama, G.; et al. Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal. N. Engl. J. Med. 2019, 381, 2209–2218.
Verma G, Rajgopal SK, Kashyap P, Sharma U. Case report on typhoid patients. JCIMCR 3:1706.doi.org/10.52768/2766-7820/1206,(2022).
Wang XY, Ansaruzzaman M, Vaz R, et al: Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population. BMC Infect Dis 2006;6:17.
Zghair, Abdulrazzaq N., Nazar Sh Mohammed, and Sumayah Faruq Kasim. "Gene Sequencing of Hepatitis C Virus Isolated from Patients with Liver Diseases." Journal of Pure & Applied Microbiology 17.2 (2023).
View Dimensions
View Altmetric
Save
Citation
View
Share